If you already have a vertigo-oriented supplement page, label, review, or checkout open, keep it open. Use this page as a six-step buyer audit plus a short professional-context gate. You are not trying to prove that a supplement works. You are deciding whether the specific product in front of you deserves CONTINUE COMPARING, whether the purchase should PAUSE, or whether you should WALK AWAY.

Outcome Meaning
CONTINUE COMPARING No defined blocker remains within this buying framework. Keep investigating the product; do not treat the outcome as approval.
PAUSE A material fact, professional-context question, evidence question, quality claim, or transaction term needs to be resolved before buying.
WALK AWAY A verified material integrity, evidence, safety-positioning, seller, or transaction problem makes continued consideration of the current product or offer unreasonable.

Keep these beside you if available: the product page, Supplement Facts/label, any evidence links or citations, reviews, and the checkout/terms page.

Before the audit: is this still a shopping decision?

A shopping framework is not the right tool for every situation. PAUSE the purchase decision if you are taking medication, are pregnant or nursing, are preparing for surgery, have a relevant chronic medical condition, or are unsure whether the product is suitable for you. Those are questions for an appropriate clinician or pharmacist, not a generic buyer checklist. Dietary supplements can interact with medications, and supplement use can matter around surgery. [1][2][17]

Also pause shopping if the vertigo or dizziness is new, persistent, worsening, recurrent, or otherwise concerning. Use the separate guide on when vertigo or dizziness should be medically assessed rather than trying to solve that question inside a product audit. [3][20]

If you think the dizziness or vertigo could be part of a medical emergency, stop shopping and seek emergency care now. [4]

If none of those professional-context issues applies, continue with the product audit.

Step 1: Write down the product's actual claim

Do not start with the ingredient list. Start with the claim.

Copy the main sentence, headline, label statement, video promise, or checkout message that is asking you to believe something about the product. Then rewrite the takeaway in plain language.

Ask:

  • What is the seller explicitly saying?
  • What would a reasonable buyer take away from the page as a whole?
  • Is the claim about the finished product, a single ingredient, a body function, a symptom or condition, safety, quality, or a transaction term?
  • Does the page rely on words such as “may,” “supports,” “helps,” or “natural” as though those words remove the need for evidence? They do not. Express and implied health claims are evaluated in context, and objective health-benefit claims need appropriate substantiation. [5][18]

A scientific-looking citation does not answer the question by itself. Neither does “doctor recommended,” a testimonial, or an ingredient name that appears in research. Your task is to identify the proposition that needs support.

One more boundary matters: dietary supplements are regulated in the United States, but FDA does not generally preapprove them for safety or effectiveness before marketing. Market availability, facility-related language, or quality-system language therefore should not be read as an FDA efficacy approval. [6][7]

Write one sentence before moving on:

The product is asking me to believe that ____________________.

That sentence is the target for Step 2.

Step 2: Match the evidence to the claim

This is the core of the audit. Evidence is useful only to the extent that it fits the claim you just wrote down.

Ingredient evidence does not automatically become evidence that a multi-ingredient finished product works. A study can also become less relevant when the ingredient form, amount, population, condition, measured outcome, duration, or study design does not materially match what the seller is asking you to believe. [5][17]

Claim-to-Evidence Fit Card

First identify what kind of support the seller is showing: a finished-product human study, an ingredient study, observational evidence, mechanism/animal/in-vitro evidence, a testimonial, a quality certificate or COA, or simply a marketing assertion.

A biologically plausible mechanism can be a reason to investigate further, but it is not the same thing as evidence of human clinical efficacy. [5]

Then run this fit scan:

Fit question What to check
Same finished product/formula? Was the marketed formula itself studied, or is the page relying on one ingredient or a different formulation?
Same ingredient identity/form? Is the ingredient in the study materially the same identity, extract, form, or standardization as the one in the product where that distinction matters?
Materially relevant amount? Is the product amount known, and is it materially comparable with the amount used in the cited evidence?
Relevant population? Were the people studied materially relevant to the claim being made?
Relevant condition/deficiency? Was the condition or deficiency relevant to the claim actually studied, rather than a different problem being generalized?
Same outcome? Did the study measure the outcome the seller is promising, rather than a mechanism or surrogate being stretched into a broader claim?
Relevant duration? Was the study long enough to address the duration implied by the claim?
Study design capable of addressing the claim? Where the seller is making a causal efficacy claim, was the study design capable of separating product effects from other explanations?

Now assign one evidence-fit label:

Evidence label What it means for this audit
DIRECT SUPPORT The materially same finished product/formula and the relevant claim dimensions were directly studied. This supports continued comparison only; it does not establish individual safety or medical suitability.
RELEVANT BUT INDIRECT The evidence bears on the claim but does not directly test the marketed finished product or has nonfatal mismatches. Do not present it as finished-product proof.
LIMITED / UNCERTAIN The support is sparse, weak, mixed, imprecise, methodologically limited, or too indirect for a confident product conclusion. A material uncertainty usually means PAUSE.
MISMATCHED A material difference in product/formula, form, amount, population/condition, outcome, duration, or design makes the evidence a poor fit for the marketed claim. Resolve ambiguity or pause; a clear material mismatch presented as finished-product proof can become a walk-away issue.
NO SUPPORT IDENTIFIED No sufficiently relevant credible support was identified in the material reviewed for the claim. This is deliberately narrower than saying “no evidence exists.”

A particularly important phrase to translate is “clinically studied ingredients.” That can mean an ingredient has been studied somewhere under particular conditions. It is not the same statement as “this finished product was studied.” [5][17]

If a proprietary blend or missing form/amount prevents you from deciding whether the cited research actually matches the product, do not invent the missing information. That is a PAUSE.

If your real question is broader—whether supplements as a category are worth considering for vertigo—use the separate guide to what the broader evidence says about supplements for vertigo. This page stays focused on the specific product already in front of you.

Step 3: Check the label and product transparency

A useful label check has two different jobs. One is to recognize the U.S. legal baseline. The other is to ask whether the product gives you enough detail to perform the evidence audit. Those are not the same thing.

Legal Baseline vs VRHQ Transparency Check

Check LEGAL BASELINE VRHQ TRANSPARENCY SIGNAL
Supplement Facts Dietary supplements generally use a Supplement Facts panel under applicable labeling rules and exceptions. [8][9][10] A legible, current panel is easy to find before purchase.
Serving information Serving size and, generally, servings per container are part of Supplement Facts requirements, subject to applicable exceptions. [9][10] The serving information is clear enough to compare the marketed use with the evidence.
Ingredient identity Dietary ingredients are identified under applicable labeling rules. [9][10] The identity is specific enough to determine whether the cited evidence actually matches.
Ingredient amounts Amounts are generally declared subject to applicable rules, including proprietary-blend provisions. [9][10] Individual amounts are disclosed when they materially affect evidence matching.
Proprietary blends A proprietary blend can be permitted to disclose the total blend amount while listing blend ingredients without each individual amount under applicable rules. A proprietary blend is not inherently unlawful. [9][10] Individual ingredient amounts are more useful when a product claim depends on comparing the marketed amount with research.
Manufacturer / packer / distributor information The label baseline includes responsible-business information under applicable rules. [8] The responsible party is easy to identify and consistent with the product and seller information.
Form / extract / standardization detail Do not assume every evidence-relevant technical detail is a universal label requirement. When form, extract, or standardization materially determines whether research matches the product, clear disclosure is a strong transparency signal.

The decision rule is simple: do not turn a VRHQ transparency preference into a legal accusation. If a material amount or form is missing and that prevents evidence matching, pause because the evidence question is unresolved. If you suspect a legal labeling problem, treat it as a compliance concern requiring current verification rather than declaring a real product illegal from this checklist alone.

Step 4: Interpret testing, CGMP, seals and COAs correctly

Quality information can be useful. It is not a substitute for efficacy evidence.

Quality signal: CAN TELL ME / CANNOT TELL ME

Signal CAN TELL ME CANNOT TELL ME
CGMP Information about manufacturing controls and specifications within the dietary-supplement CGMP framework. [11] That the product is FDA approved, works for vertigo, or is suitable for you. [7][11]
Third-party testing / certification Only the identity, content, contaminants, manufacturing, or other attributes actually covered by the named program or test. [1][12] Clinical efficacy, universal safety, or outcomes outside the verified scope.
Quality seal Program-defined quality assertions if the seal is authentic, current, and product-specific. [1][12] FDA endorsement or proof that the product improves vertigo.
Certificate of Analysis (COA) Results for the documented sample/lot, analytes, methods or limits, date, and issuer when the document is authentic and matched to the product. [1][11] All-lot consistency, every untested contaminant, clinical efficacy, or individual safety.

For any quality claim, ask four questions: Who tested? What was tested? Which product or lot? What exactly was verified?

“Lab tested” without answers to those questions is too vague to carry much weight. A strong verified quality signal can support continued comparison on quality grounds. It cannot be converted into evidence that the product works for vertigo.

If a material testing or certification claim cannot be verified, PAUSE. If you verify that a material quality claim is false or materially misrepresented, that can support WALK AWAY.

Step 5: Use reviews for the questions they can answer

Reviews are useful when you ask them questions they can realistically answer.

Reviews Are for Experience, Not Proof

USE REVIEWS FOR DO NOT USE REVIEWS AS
Shipping patterns Efficacy proof
Packaging or product-condition patterns Safety proof
Billing and recurring-charge experience Proof of an expected personal health outcome
Support responsiveness A substitute for controlled human evidence
Cancellation and refund experience Evidence that a health claim is substantiated
Recurring practical problems worth verifying directly Proof that an expert or “doctor recommended” presentation validates the formula

Consumer anecdotes and endorsements are not scientific substantiation for a health-benefit claim. A sincere report that someone felt better is still an anecdote; it does not establish that the product caused the result or that another buyer should expect it. [5][14]

Use reviews as leads. If several buyers describe the same billing, refund, cancellation, packaging, or support problem, go back to the operative terms and verify it. Current FTC materials also address deceptive review practices, but do not label a seller's reviews fake or manipulated without verified facts. [13][14][19]

Step 6: Check the seller and transaction terms before paying

A product can have a polished evidence story and still be a poor buying decision if you cannot tell who is charging you, what the total cost is, whether the billing repeats, or how the advertised refund process works.

Before-You-Pay Terms Check

Check What to verify before entering payment information
Seller / counterparty Who is actually selling and charging you? Is that identity consistent across the product page, checkout, and terms?
Support path Is there a usable way to contact support about an order or billing problem?
One-time vs recurring billing Does the purchase repeat? If so, what amount and frequency are disclosed?
Total / landed cost What is the product quantity, shipping, and any unavoidable charge visible before purchase?
Shipping What shipping charge and material delivery terms apply to this order?
Refund / guarantee terms What is the window, what is excluded, what conditions apply, and what does the guarantee actually promise?
Return process What steps are required, and are any return-shipping or handling responsibilities disclosed?
Cancellation path If billing recurs, how does the seller say you stop future charges, and does that method match the operative terms?

Most of these are VRHQ buying checks, not a claim that federal law requires every supplement seller to use VRHQ's preferred commercial practices.

For covered online negative-option transactions, the federal ROSCA baseline includes clear disclosure of material terms before billing information, express informed consent, and a simple mechanism to stop recurring charges. [15][16] Do not rely on stale summaries of a universal federal “click-to-cancel” rule: the FTC's broader 2024 amended Negative Option Rule was vacated in 2025, and current negative-option law and rulemaking should be verified in context before publication or legal application. [16]

If the total cost, recurring billing, refund, cancellation, seller identity, or support path is materially unclear, PAUSE. If a materially deceptive or irreconcilable transaction practice is verified, WALK AWAY.

Make the decision: Continue Comparing, Pause, or Walk Away

Do not add up points. This is a non-compensatory decision: attractive packaging, a quality seal, positive reviews, or a generous guarantee cannot cancel a material professional-context, evidence, integrity, or transaction problem.

Outcome Use it when What to do next What it does not mean
CONTINUE COMPARING No professional-context pause applies; the claim is specific enough to evaluate; there is enough product information to assess material evidence fit; the evidence is not being materially overstated; quality claims stay within their verified scope; reviews are not being used as clinical proof; transaction terms are sufficiently clear; and no material integrity concern remains unresolved. Keep comparing this product or other products with the same framework. Not a pass, certification, endorsement, proof of efficacy, proof of safety, proof of individual suitability, clinical appropriateness, or medical recommendation.
PAUSE Professional context is needed; a material product/evidence fact is unknown; a proprietary blend or missing form/amount blocks evidence matching; a claim or quality assertion needs verification; seller/billing/refund/cancellation/support terms are materially unclear; or a legal/compliance question needs qualified verification. Do not buy yet. Verify the missing fact, ask an appropriate clinician or pharmacist when relevant, use the medical-assessment path when appropriate, or simply decide not to buy. Re-evaluation is optional. Not a sales objection and not a promise that purchase should resume later.
WALK AWAY You verify a material health-claim misrepresentation; a material evidence mismatch is presented as finished-product proof and remains unresolved; a material testing/quality claim is false or materially misrepresented; verified review/independence manipulation is material; transaction/refund/recurring terms are materially deceptive or irreconcilable; unsafe positioning discourages appropriate assessment; or a material seller/product/terms concern cannot responsibly be resolved. End consideration of the current product or offer. You can choose not to buy anything, step back to broader category evidence, or follow an appropriate medical/professional path. Not a diagnosis, not a declaration that all supplements are ineffective, and not an instruction to substitute another seller.

Use this precedence if more than one issue appears:

  1. Professional or medical context first. If shopping should pause, stop the purchase decision there.
  2. Verified material integrity problems next. A real walk-away trigger ends consideration of the current product or offer.
  3. Resolvable material unknowns. Pause until they are resolved; choosing not to buy is always a valid outcome.
  4. Only then: CONTINUE COMPARING.

These integrity triggers are VRHQ editorial decision rules informed by health-advertising, endorsement, review, and transaction principles; they are not product-specific legal findings. [5][14][15][19]

A Continue Comparing result is deliberately modest. It means only that no defined blocker remains within this buying framework. It does not establish that the supplement is effective for vertigo, safe for you, clinically appropriate, or medically recommended. [1][5]

Sources

  1. NIH Office of Dietary Supplements — Dietary Supplements: What You Need to Know — https://ods.od.nih.gov/factsheets/WYNTK-Consumer/
  2. National Center for Complementary and Integrative Health — Using Dietary Supplements Wisely — https://www.nccih.nih.gov/health/using-dietary-supplements-wisely
  3. MedlinePlus / U.S. National Library of Medicine — Dizziness: Medical Encyclopedia — https://medlineplus.gov/ency/article/003093.htm
  4. Centers for Disease Control and Prevention — Signs and Symptoms of Stroke — https://www.cdc.gov/stroke/signs-symptoms/index.html
  5. Federal Trade Commission — Health Products Compliance Guidance — https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
  6. U.S. Food and Drug Administration — Questions and Answers on Dietary Supplements — https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
  7. U.S. Food and Drug Administration — Is It Really “FDA Approved”? — https://www.fda.gov/consumers/consumer-updates/it-really-fda-approved
  8. U.S. Food and Drug Administration — Dietary Supplement Labeling Guide: Chapter I — General Dietary Supplement Labeling — https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide-chapter-i-general-dietary-supplement-labeling
  9. U.S. Food and Drug Administration — Dietary Supplement Labeling Guide: Chapter IV — Nutrition Labeling — https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide-chapter-iv-nutrition-labeling
  10. Electronic Code of Federal Regulations — 21 CFR § 101.36 — Nutrition labeling of dietary supplements — https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-C/section-101.36
  11. Electronic Code of Federal Regulations — 21 CFR Part 111 — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements — https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
  12. NIH Office of Dietary Supplements — Frequently Asked Questions (FAQ) — https://ods.od.nih.gov/HealthInformation/ODS_Frequently_Asked_Questions.aspx
  13. Federal Trade Commission — The Consumer Reviews and Testimonials Rule: Questions and Answers — https://www.ftc.gov/business-guidance/resources/consumer-reviews-testimonials-rule-questions-answers
  14. Federal Trade Commission — FTC's Endorsement Guides: What People Are Asking — https://www.ftc.gov/business-guidance/resources/ftcs-endorsement-guides-what-people-are-asking
  15. Federal Trade Commission — Restore Online Shoppers' Confidence Act (ROSCA) — FTC summary/enforcement baseline — https://www.ftc.gov/business-guidance/blog/2016/09/negative-options-make-them-positive
  16. Federal Trade Commission — Negative Option Rule: Advance Notice of Proposed Rulemaking (2026) — https://www.ftc.gov/system/files/ftc_gov/pdf/p064202negativeoptionruleanprm.pdf
  17. National Center for Complementary and Integrative Health — Dietary and Herbal Supplements — https://www.nccih.nih.gov/health/dietary-and-herbal-supplements
  18. U.S. Food and Drug Administration — Small Entity Compliance Guide on Structure/Function Claims — https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-structurefunction-claims
  19. Electronic Code of Federal Regulations — 16 CFR Part 465 — Rule on the Use of Consumer Reviews and Testimonials — https://www.ecfr.gov/current/title-16/chapter-I/subchapter-D/part-465
  20. National Institute on Deafness and Other Communication Disorders — Balance Disorders — https://www.nidcd.nih.gov/health/balance-disorders